Search research articles
Contact Us
Filters
Showing results (41-50 of 333) with videos related to
Page
of 34
Sort By:
Immunobiology
|
August 23, 2011
Complement activation as a biomarker for Alzheimer's disease
Mohammed Aiyaz, Michelle K Lupton, Petroula Proitsi, et al.
BMC Research Notes
|
November 8, 2017
Effects of freezer storage time on levels of complement biomarkers
Angharad R Morgan, Caroline O'Hagan, Samuel Touchard, et al.
Plos One
|
July 19, 2012
Ageing increases vulnerability to aβ42 toxicity in Drosophila
Iain Rogers, Fiona Kerr, Pedro Martinez, et al.
Molecular and Cellular Neurosciences
|
January 9, 2007
Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella
Naushaba Nayeem, Fiona Kerr, Heike Naumann, et al.
The Journal of Prevention of Alzheimer'S Disease
|
December 1, 2025
The evolution of Alzheimer's target identification: Towards a fusion of artificial and cellular intelligence
Gayle Wittenberg, Fiona Elwood, Andrea Houghton, et al.
Neuroscience Letters
|
April 3, 2007
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
Claudie Hooper, Eirini Meimaridou, Mahvash Tavassoli, et al.
Expert Review of Proteomics
|
April 12, 2007
Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers
Simon Lovestone, Andreas Güntert, Abdul Hye, et al.
Journal of Neurochemistry
|
June 15, 2011
Transcriptomic profiles of Wnt3a and insulin in primary cultured rat cortical neurones
Claudie Hooper, Richard Killick, Cathy Fernandes, et al.
International Journal of Geriatric Psychiatry
|
January 9, 2008
A feasibility and tolerability study of lithium in Alzheimer's disease
Alastair Macdonald, Kate Briggs, Michaela Poppe, et al.
Psychoneuroendocrinology
|
January 30, 2004
Do antidepressants regulate how cortisol affects the brain?
Carmine M Pariante, Sarah A Thomas, Simon Lovestone, et al.
Page
of 34
Search research articles
Search
Showing results (41-50 of 333) with videos related to
Sort By:
Page
of 34
Immunobiology
|
August 23, 2011
Complement activation as a biomarker for Alzheimer's disease
Mohammed Aiyaz, Michelle K Lupton, Petroula Proitsi, et al.
BMC Research Notes
|
November 8, 2017
Effects of freezer storage time on levels of complement biomarkers
Angharad R Morgan, Caroline O'Hagan, Samuel Touchard, et al.
Plos One
|
July 19, 2012
Ageing increases vulnerability to aβ42 toxicity in Drosophila
Iain Rogers, Fiona Kerr, Pedro Martinez, et al.
Molecular and Cellular Neurosciences
|
January 9, 2007
Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella
Naushaba Nayeem, Fiona Kerr, Heike Naumann, et al.
The Journal of Prevention of Alzheimer'S Disease
|
December 1, 2025
The evolution of Alzheimer's target identification: Towards a fusion of artificial and cellular intelligence
Gayle Wittenberg, Fiona Elwood, Andrea Houghton, et al.
Neuroscience Letters
|
April 3, 2007
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
Claudie Hooper, Eirini Meimaridou, Mahvash Tavassoli, et al.
Expert Review of Proteomics
|
April 12, 2007
Proteomics of Alzheimer's disease: understanding mechanisms and seeking biomarkers
Simon Lovestone, Andreas Güntert, Abdul Hye, et al.
Journal of Neurochemistry
|
June 15, 2011
Transcriptomic profiles of Wnt3a and insulin in primary cultured rat cortical neurones
Claudie Hooper, Richard Killick, Cathy Fernandes, et al.
International Journal of Geriatric Psychiatry
|
January 9, 2008
A feasibility and tolerability study of lithium in Alzheimer's disease
Alastair Macdonald, Kate Briggs, Michaela Poppe, et al.
Psychoneuroendocrinology
|
January 30, 2004
Do antidepressants regulate how cortisol affects the brain?
Carmine M Pariante, Sarah A Thomas, Simon Lovestone, et al.
Page
of 34